Antoine Adamantidis, PhD, is interested in the underlying neural mechanism for wakefulness or vigilance states.

Ng Ying Kin uses neurochemical analyses to identify peripheral biological markers for various psychiatric disorders.

Lalit Srivastava, has conducted research on schizophrenia and dopamine, a brain chemical implicated in its development.

Michael Meaney examines the molecular mechanisms by which maternal care alters gene expression.

Bruno Giros characterizes the neurobiology of schizophrenia and develops improved genetic animal models of this illness.

Suzanne King is investigating  risk factors for schizophrenia, such as prenatal stress, obstetric complications, and cannabis use.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Sylvain Williams pursues several complimentary lines of study aimed towards elucidating the cause of Alzheimer Disease.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Howard Steiger contributed to the advancement of knowledge regarding causal mechanisms and clinical management of eating disorders.